Locations:
Search
Diagnosis and treatment of MOG antibody-associated disease
Care guidelines have been crucial to progress in TBI care over the past 25 years
Mounting evidence of possible shared genetic predisposition
Recently launched first-of-kind study aims to address an unmet therapeutic need
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Biomarker promises a practical way to reduce misdiagnoses
AHA scientific statement offers best practices to improve care for high-risk populations
Relapse rates were lower with oral or infusion therapy after initial injectable DMT
No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy
We now have an expanded toolbox to extend survival and lessen treatment toxicity
Insights on leveraging collaboration and advocacy to develop and conduct needed trials
Advertisement
Advertisement